z-logo
open-access-imgOpen Access
The association between proton pump inhibitors and myocardial infarction: What do food and drug administration data tell us?
Author(s) -
Jiun Ming Tan,
Richard Parsons,
Tin Fei Sim,
Ya Ping Lee
Publication year - 2019
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/jrpp.jrpp_19_73
Subject(s) - medicine , food and drug administration , myocardial infarction , drug , administration (probate law) , pharmacology , association (psychology) , cardiology , philosophy , epistemology , political science , law
There is limited and conflicting evidence on the association between proton pump inhibitors (PPIs) and myocardial infarction (MI). This study aims to examine the occurrence of MI associated with PPI use from the Food and Drug Administration (FDA) Adverse Event Reporting System database.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here